Sanjai Saxena

Prof. Dr. Sanjai Saxena

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2018 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Sunil DeshmukhSunil Deshmukh
Sunil Deshmukh
MGManish Kumar Gupta
Manish Kumar Gupta
VPVed Prakash
Ved Prakash
Sanjai SaxenaSanjai Saxena
Sanjai Saxena
The emerging and reemerging forms of fungal infections encountered in the course of allogeneic bone marrow transplantations, cancer therapy, and organ transplants have necessitated the discovery of antifungal compounds with enhanced efficacy and better compatibility. A very limited number of antifungal compounds are in practice against the various forms of topical and systemic fungal infections. The trends of new antifungals being introduced into the market have remained insignificant while resistance towards the introduced drug has apparently increased, specifically in patients undergoing long-term treatment. Considering the immense potential of natural microbial products for the isolation and screening of novel antibiotics for different pharmaceutical applications as an alternative source has remained largely unexplored. Endophytes are one such microbial community that resides inside all plants without showing any symptoms with the promise of producing diverse bioactive molecules and novel metabolites which have application in medicine, agriculture, and industrial set ups. This review substantially covers the antifungal compounds, including volatile organic compounds, isolated from fungal endophytes of medicinal plants during 2013–2018. Some of the methods for the activation of silent biosynthetic genes are also covered. As such, the compounds described here possess diverse configurations which can be a step towards the development of new antifungal agents directly or precursor molecules after the required modification.

8 February 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Sunil DeshmukhSunil Deshmukh
Sunil Deshmukh
Laurent DufosséLaurent Dufossé
Laurent Dufossé
HCHemraj Chhipa
Hemraj Chhipa
Sanjai SaxenaSanjai Saxena
Sanjai Saxena
GMGirish Badrinath Mahajan
Girish Badrinath Mahajan
MGManish Kumar Gupta
Manish Kumar Gupta
Antibiotic resistance is becoming a burning issue due to the frequent use of antibiotics for curing common bacterial infections, indicating that we are running out of effective antibiotics. This has been more obvious during recent corona pandemics. Similarly, enhancement of antimicrobial resistance (AMR) is strengthening the pathogenicity and virulence of infectious microbes. Endophytes have shown expression of various new many bioactive compounds with significant biological activities. Specifically, in endophytic fungi, bioactive metabolites with unique skeletons have been identified which could be helpful in the prevention of increasing antimicrobial resistance. The major classes of metabolites reported include anthraquinone, sesquiterpenoid, chromone, xanthone, phenols, quinones, quinolone, piperazine, coumarins and cyclic peptides. In the present review, we reported 451 bioactive metabolites isolated from various groups of endophytic fungi from January 2015 to April 2021 along with their antibacterial profiling, chemical structures and mode of action. In addition, we also discussed various methods including epigenetic modifications, co-culture, and OSMAC to induce silent gene clusters for the production of noble bioactive compounds in endophytic fungi.

11 February 2019 in Journal of the Brazilian Society of Mechanical Sciences and Engineering
Verified
Journal Article
Closed access
PDF file
DSDaljeet Singh
Daljeet Singh
ABATUL BABBAR
ATUL BABBAR
VJVivek Jain
Vivek Jain
DGDheeraj Gupta
Dheeraj Gupta
Sanjai SaxenaSanjai Saxena
Sanjai Saxena
VDVagish Dwibedi
Vagish Dwibedi

1 May 2001 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
Sanjai SaxenaSanjai Saxena
Sanjai Saxena
APAkhilesh K. Pandey
Akhilesh K. Pandey

1 July 2016 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
RNRenu Narain
Renu Narain
Sanjai SaxenaSanjai Saxena
Sanjai Saxena
AGAchal Kumar Goyal
Achal Kumar Goyal
Purpose: Currently cardiovascular diseases (CVDs) are the main cause of death worldwide. Disease risk estimates can be used as prognostic information and support for treating CVDs. The commonly used Framingham risk score (FRS) for CVD prediction is outdated for the modern population, so FRS may not be accurate enough. In this paper, a novel CVD prediction system based on machine learning is proposed. Methods: This study has been conducted with the data of 689 patients showing symptoms of CVD. Furthermore, the dataset of 5,209 CVD patients of the famous Framingham study has been used for validation purposes. Each patient’s parameters have been analyzed by physicians in order to make a diagnosis. The proposed system uses the quantum neural network for machine learning. This system learns and recognizes the pattern of CVD. The proposed system has been experimentally evaluated and compared with FRS. Results: During testing, patients’ data in combination with the doctors’ diagnosis (predictions) are used for evaluation and validation. The proposed system achieved 98.57% accuracy in predicting the CVD risk. The CVD risk predictions by the proposed system, using the dataset of the Framingham study, confirmed the potential risk of death, deaths which actually occurred and had been recorded as due to myocardial infarction and coronary heart disease in the dataset of the Framingham study. The accuracy of the proposed system is significantly higher than FRS and other existing approaches. Conclusion: The proposed system will serve as an excellent tool for a medical practitioner in predicting the risk of CVD. This system will be serving as an aid to medical practitioners for planning better medication and treatment strategies. An early diagnosis may be effectively made by using this system. An overall accuracy of 98.57% has been achieved in predicting the risk level. The accuracy is considerably higher compared to the other existing approaches. Thus, this system must be used instead of the well-known FRS.

2 March 2014 in Annals of Microbiology
Verified
Journal Article
Closed access
PDF file
Sanjai SaxenaSanjai Saxena
Sanjai Saxena
VMVineet Meshram
Vineet Meshram
NKNeha Kapoor
Neha Kapoor